Stock Price
6.11
Daily Change
0.16 2.61%
Monthly
8.24%
Yearly
16.06%
Q2 Forecast
5.82

Ardelyx reported $244.35M in Ordinary Share Capital for its fiscal quarter ending in December of 2025.





Ordinary Share Capital Change Date
Abbott USD 1.74B 23.39B Sep/2025
Amgen USD 539M 1000K Dec/2025
Ardelyx USD 244.35M 1.38M Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
Corcept Therapeutics USD 105.97M 842K Dec/2025
Curis USD 12.93M 12.87M Dec/2025
TG Therapeutics USD 155.21M 2.81M Sep/2025
United Therapeutics USD 43.64M 740K Dec/2025
Xoma USD 87K 1000 Jun/2024